Syncona : Corporate Presentation - August 2023 -Today at 11:40 am
Synconaltd.com September 2023 Cautionary statement ...
Source: marketscreener.com
📰 Syncona Ltd News
Page 4 - Syncona Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Syncona Ltd. Real-time updates on events, politics, business and more.
Syncona notes clinical progress of portfolio firm Freeline
Syncona Ltd - London-based healthcare investor - Notes second quarter results announcement from its Nasdaq-listed portfolio company Freeline Therapeutics Holdings PLC. Says the key highlights include... -Today at 08:58 am- MarketScreener
Source: marketscreener.com
Syncona says net asset value slips 1% in first quarter
Syncona Ltd - London-based healthcare investor - Net asset value at June 30 is 184.6 pence per share, down 1.0% from 186.5p on March 31. NAV total return also was negative 1.0% for the recent three... -Today at 04:34 am- MarketScreener
Source: marketscreener.com
Syncona : Quarterly Update covering the period 01 April 2023 to 30 June 2023
Syncona Limited First Quarter Update Continued progress and active management of maturing portfolio as late-stage companies approach ... -Today at 10:37 am- MarketScreener
Chris Hollowood Syncona Ltd Syncona Investment Management Syncona Limited Syncona Investment Management Limited Autolus Therapeutics
Source: marketscreener.com
CHANCELLOR OF THE EXCHEQUER JOINS J.P. MORGAN, CANARY WHARF GROUP AND KADANS SCIENCE PARTNER AT J.P. MORGAN HEALTHCARE INNOVATION SYMPOSIUM
CHANCELLOR OF THE EXCHEQUER JOINS J.P. MORGAN, CANARY WHARF GROUP AND KADANS SCIENCE PARTNER AT J.P. MORGAN HEALTHCARE INNOVATION SYMPOSIUM 23 June 2023: Together with Canary Wharf Group and Kadans Science Partner, J.P. Morgan hosted an exclusive EMEA Healthcare Innovation Symposium yesterday, which saw global...
Source: pharmiweb.com
Syncona : Full Year Results for the 12 months ended 31 March 2023
Syncona Ltd, a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, today announces its Annual Results for the 12 months ended... | June 15, 2023
Chris Hollowood Syncona Ltd Advisory Group Syncona Investment Management Annual Results Beacon Therapeutics
Source: marketscreener.com
ECB rate decision and Halma results on Thursday
Thursday offers up some of Londons less glamorous stocks, including health and safety specialist Halma PLC (LSE:HLMA), shower trays maker Norcros and Bunzl...
Source: proactiveinvestors.co.uk
AstraZeneca hails deal with Quell; positive danicopan data
AstraZeneca PLC on Friday reported positive phase 3 trial data for its oral drug danicopan and struck an agreement with London-based biopharma company Quell Therapeutics Ltd. The Cambridge-based... | June 9, 2023
Source: marketscreener.com
Week ahead: Fed decision, Shell returns strategy and Tesco update
Updates from Shell, Tesco, Ashtead, Bellway and Halma should keep investors interested, while interest rate decisions are due from the Federal Reserve and...
Source: proactiveinvestors.co.uk
Syncona investee Freeline swings to first-quarter profit
Syncona Ltd - London-based investor in healthcare companies - Reports first-quarter results of investee Freeline Therapeutics Holdings PLC. Freeline is a clinical-stage biotechnology company.... | May 30, 2023
City Of United Kingdom Michael Parini Alliance News Alliance News Ltd Freeline Therapeutics Holdings
Source: marketscreener.com